Evidence map›Paper›PMID 21376939›Full record

ReviewGastroenterology2011

American Gastroenterological Association technical review on the management of Barrett's esophagus.

Stuart J Spechler, Prateek Sharma, Rhonda F Souza, John M Inadomi, Nicholas J Shaheen, American Gastroenterological Association

Abstract readReview
In one paragraph

Review in Gastroenterology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Chemoprevention of Barrett's Esophagus: a Systematic Review and Comprehensive Assessment of Bias.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stuart J SpechlerVA North Texas Health Care System and University of Texas Southwestern Medical Center Dallas, Texas, USA.
Prateek Sharma
Rhonda F Souza
John M Inadomi
Nicholas J Shaheen
American Gastroenterological Association

Funding

Role of Acid in the Development of Barrett's EsophagusR01DK063621 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI SOUZA, RHONDA F, SPECHLER, STUART JON · 2002 to 2015
$3.4M
Improving Gastrointestinal Disease Outcomes in Vulnerable PopulationsK24DK080941 · NIDDK · UNIVERSITY OF WASHINGTON · PI INADOMI, JOHN MATTHEW · 2008 to 2019
$1.8M
Basic and Clinical Studies on the Role of Bile Acids in Barrett's EsophagusR01CA134571 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SOUZA, RHONDA F, SPECHLER, STUART JON · 2009 to 2013
$1.3M
NCI NIH HHS R01 CA134571NCI NIH HHS R01-CA134571NIDDK NIH HHS K24 DK080941NIDDK NIH HHS R01 DK063621NIDDK NIH HHS R01-DK63621
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaAnti-Inflammatory Agents, Non-SteroidalBarrett EsophagusEsophageal NeoplasmsEsophagectomyEsophagoscopyEvidence-Based MedicineHumansMass ScreeningPatient SelectionPractice Guidelines as TopicPrecancerous ConditionsProton Pump InhibitorsRisk AssessmentRisk FactorsSocieties, MedicalAnti-Inflammatory Agents, Non-SteroidalProton Pump Inhibitors

Identifiers

PMID21376939
PMCPMC3258495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.